S6K1 Alternative Splicing Modulates Its Oncogenic Activity and Regulates mTORC1
Ribosomal S6 kinase 1 (S6K1) is a major mTOR downstream signaling molecule that regulates cell size and translation efficiency. Here, we report that short isoforms of S6K1 are overproduced in breast cancer cell lines and tumors. Overexpression of S6K1 short isoforms induces transformation of human b...
Main Authors: | Vered Ben-Hur, Polina Denichenko, Zahava Siegfried, Avi Maimon, Adrian Krainer, Ben Davidson, Rotem Karni |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-01-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124712004172 |
Similar Items
-
Dopamine neuron morphology and output are differentially controlled by mTORC1 and mTORC2
by: Polina Kosillo, et al.
Published: (2022-07-01) -
Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
by: Haiyang Tang, PhD, et al.
Published: (2018-12-01) -
Regulation of Autophagy through TORC1 and mTORC1
by: Takeshi Noda
Published: (2017-07-01) -
Disruption of the Keap1-mTORC2 axis by cancer-derived Keap1/mLST8 mutations leads to oncogenic mTORC2-AKT activation
by: Yingji Chen, et al.
Published: (2023-11-01) -
mTORC1 and mTORC2 differentially promote natural killer cell development
by: Chao Yang, et al.
Published: (2018-05-01)